Results 61 to 70 of about 18,613 (204)

Hypomagnesemia after aneurysmal subarachnoid hemorrhage

open access: yes, 2003
OBJECTIVE: Hypomagnesemia frequently occurs in hospitalized patients, and it is associated with poor outcome. We assessed the frequency and time distribution of hypomagnesemia after aneurysmal subarachnoid hemorrhage (SAH) and its relationship to the ...
Rinkel, Gabriël J.E.   +5 more
core   +1 more source

Natural product‐derived TRPM7 channel inhibitors in neurological injury: Mechanisms, pharmacological potential and translational challenges

open access: yesBritish Journal of Pharmacology, EarlyView.
Disruption of intracellular ionic homeostasis is a convergent pathological feature across diverse neurological injuries and disorders, including ischaemic and haemorrhagic stroke, hypoxic–ischaemic brain injury, traumatic brain injury, epilepsy and brain tumour.
Xinyang Zhang   +5 more
wiley   +1 more source

ASSOCIATION OF HYPOMAGNESEMIA AND DIABETIC NEPHROPATHY

open access: yes, 2020
Background: Hypomagnesaemia is a regular sequel of type II diabetes mellitus. Objective: This research has aimed to highlight the association of hypomagnesemia in type II diabetes in order to identify and treat the electrolyte disorder to prevent ...
Dr Nehan Shakeel, Dr Fatima Jabbar, Dr Iqra Raees
core   +1 more source

Association between magnesium level during hospitalization and venous thromboembolism (VTE) up to 30 days after hospitalization in acutely ill, hospitalized patients, 65 to 90 years old. a retrospective cohort analysis of 6,428 patients

open access: yesBMC Geriatrics
Background Hypomagnesemia, known to be associated with physiologic stress and states of inflammation, is also known to be common in acutely ill, hospitalized patients.
Sela O.   +9 more
doaj   +1 more source

Phase II Study of Cisplatin/Gemcitabine Plus Necitumumab for Squamous NSCLC After ICI‐Platinum Therapy (WJOG14120L)

open access: yesCancer Science, EarlyView.
WJOG14120L NESSIE evaluated cisplatin, gemcitabine, and necitumumab (CGN) as second‐line therapy after ICI‐based treatment in 46 patients with advanced squamous NSCLC. ORR was 26.1%, DCR 87.0%, and median PFS 4.4 months. Although the predefined ORR threshold was not met, CGN showed modest antitumor activity with manageable toxicity.
Hiroshige Yoshioka   +15 more
wiley   +1 more source

Hypomagnesemia after ruptured middle cerebral artery aneurysms: predictive factor and pathophysiological implication

open access: yes, 2008
Hypomagnesemia was frequently present after aneurysmal subarachnoid haemorrhage. It was found in 38% of patients admitted after aneurysmal SAH and predicted the occurrence of delayed cerebral ischemia.
Chan, M. T.V.   +5 more
core   +1 more source

Additional file 6 of Association between hypomagnesemia and coagulopathy in sepsis: a retrospective observational study

open access: yes, 2022
Additional file 6: Time course of coagulation parameters in persistent hypomagnesemia and resolved hypomagnesemia on day ...
Kansuke Koyama (4807728)   +6 more
core   +1 more source

Hypomagnesemia: exploring its multifaceted health impacts and associations with blood pressure regulation and metabolic syndrome

open access: yesDiabetology & Metabolic Syndrome
This article provides a comprehensive and in-depth exploration of the multifaceted effects of Hypomagnesemia on human health, with a specific focus on its intricate associations with mechanisms regulating blood pressure and metabolic syndrome.
Wenlong Wu   +5 more
doaj   +1 more source

Multisystem developmental abnormalities and insulin resistance in ADTKD‐HNF1B with the p.E105K variant: A clinical conundrum

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims HNF1B variants cause autosomal dominant tubulointerstitial kidney disease (ADTKD‐HNF1B), but the phenotypic spectrum of variants of uncertain significance (VUS) remains incompletely defined. We aimed to characterise the multisystem phenotype associated with the HNF1B p.E105K variant and to examine the mechanism underlying insulin ...
YunZe Wang   +5 more
wiley   +1 more source

Hypomagnesemia/Hypermagnesemia

open access: yes, 2017
Hypomagnesemia is a relatively common electrolyte abnormality that may produce little to no significant clinical manifestations in patients. Commonly used medications such as proton-pump inhibitors and antidepressants can cause magnesium deficiency.
Aali Shah
core   +1 more source

Home - About - Disclaimer - Privacy